Literature DB >> 23523569

Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat.

Song Bai1, Zheng-Gui Huang, Li Chen, Jiang-Tao Wang, Bo-Ping Ding.   

Abstract

This study aimed to investigate the effect of combination of felodipine+puerarin on ACE2-Ang (1-7)-Mas axis, and to explore the protective effect of the combination against kidney in renovascular hypertensive rats. Goldblatt rats were randomly divided into 5 groups as follows: 4 groups which were treated with felodipine (Felo), puerarin (Pue), Felo+Pue, and Felo+captopril (Cap), respectively, and a control group of animals that were administrated with distilled water. Contents of Ang II and Ang (1-7) in renal tissues were determined by ELISA kit. The mRNA expression of ACE2/Mas and ACE/AT1 in kidneys was analyzed by RT-PCR. After 8weeks of treatment, compared with Goldblatt group, Felo+Pue reduced SBP, DBP and HR (p<0.01 or p<0.05), ameliorated renal interstitial fibrosis, decreased the level of Ang II and increased that of Ang (1-7), upregulated mRNA expression of ACE2 and Mas, decreased that of ACE and AT1, and downregulated protein expression of TGF-β1 in kidneys (p<0.01). Compared with Felo group, Felo+Pue decreased DBP and HR more markedly, attenuated fibrosis, decreased Ang II levels and increased those of Ang (1-7), upregulated mRNA expression of ACE2 in bilateral kidneys and that of Mas in ischemic kidney, downregulated that of ACE in bilateral kidneys and that of AT1 in ischemic kidney, and decreased expression of TGF-β1 protein significantly. In a word, a combination of Felo+Pue has a more efficient therapeutic effect on DBP and HR, and contributes to a better protection against renal interstitial fibrosis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523569     DOI: 10.1016/j.regpep.2013.03.005

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

1.  Fisetin attenuates renal ischemia/reperfusion injury by improving mitochondrial quality, reducing apoptosis and oxidative stress.

Authors:  Priyanka N Prem; Gino A Kurian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-08       Impact factor: 3.000

2.  Dietary Puerarin Supplementation Alleviates Oxidative Stress in the Small Intestines of Diquat-Challenged Piglets.

Authors:  Meng Li; Daixu Yuan; Yanhong Liu; Hui Jin; Bie Tan
Journal:  Animals (Basel)       Date:  2020-04-07       Impact factor: 2.752

Review 3.  An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin-Angiotensin System in the Treatment of Hypertension.

Authors:  Pietro De Lange-Jacobs; Asma Shaikh-Kader; Bianca Thomas; Trevor T Nyakudya
Journal:  Molecules       Date:  2020-04-30       Impact factor: 4.411

4.  Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.

Authors:  Hisashi Kai; Mamiko Kai; Hiroshi Niiyama; Norihito Okina; Motoki Sasaki; Takanobu Maeda; Atsushi Katoh
Journal:  Hypertens Res       Date:  2021-03-10       Impact factor: 3.872

5.  Renal Vascular Response to Angiotensin II Administration in Two Kidneys-One Clip Hypertensive Rats Treated with High Dose of Estradiol: The Role of Mas Receptor.

Authors:  Samira Choopani; Mehdi Nematbakhsh
Journal:  Int J Vasc Med       Date:  2021-03-01

6.  Puerarin exhibits antiinflammatory properties in gunpowder smog-induced acute lung injury in rats via regulation of the renin-angiotensin system and the NFκB signaling pathway.

Authors:  Fan Zhang; Yu Wang; Peipei Liu; Ping Di; Mianyang Li; Chengbin Wang
Journal:  Exp Ther Med       Date:  2021-05-27       Impact factor: 2.447

Review 7.  From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension.

Authors:  Sheila K Patel; Elena Velkoska; Melanie Freeman; Bryan Wai; Terase F Lancefield; Louise M Burrell
Journal:  Front Physiol       Date:  2014-06-24       Impact factor: 4.566

Review 8.  Flavonoids in Kidney Health and Disease.

Authors:  Félix Vargas; Paola Romecín; Ana I García-Guillén; Rosemary Wangesteen; Pablo Vargas-Tendero; M Dolores Paredes; Noemí M Atucha; Joaquín García-Estañ
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

Review 9.  Renin-angiotensin-aldosterone system and COVID-19 infection.

Authors:  Joachim Alexandre; Jean-Luc Cracowski; Vincent Richard; Béatrice Bouhanick
Journal:  Ann Endocrinol (Paris)       Date:  2020-04-21       Impact factor: 2.478

Review 10.  Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.

Authors:  Yan-Xi Zhou; Hong Zhang; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.